Prism Medico Pharmacy Ltd vs Starsource Multitrade Ltd Stock Comparison

Home

Insights

Stock Comparison

Last Updated on: Oct 25, 2026

Key Highlights

The Latest Trading Price of Prism Medico & Pharmacy Ltd is ₹ 31.52 as of 23 Oct 15:30 . The P/E Ratio of Prism Medico & Pharmacy Ltd changed from 47.6 on March 2026 to 47.6 on March 2026 . This represents a CAGR of 0.00% over 1 yearsThe P/E Ratio of Starsource Multitrade Ltd changed from 10.7 on March 2021 to 0 on March 2026 . This represents a CAGR of -100.00% over 6 years The Market Cap of Prism Medico & Pharmacy Ltd changed from ₹ 7.06 crore on March 2021 to ₹ 15.29 crore on March 2026 . This represents a CAGR of 13.75% over 6 yearsThe Market Cap of Starsource Multitrade Ltd changed from ₹ 2.68 crore on March 2021 to ₹ 16.68 crore on March 2026 . This represents a CAGR of 35.63% over 6 years The revenue of Prism Medico & Pharmacy Ltd for the Jun '26 is ₹ 0.09 crore as compare to the Mar '26 revenue of ₹ 0.28 crore. This represent the decline of -67.86% The revenue of Starsource Multitrade Ltd for the Jun '26 is ₹ 0.07 crore as compare to the Mar '26 revenue of ₹ 0 crore. This represent the growth of 9.2233718E16% The ebitda of Prism Medico & Pharmacy Ltd for the Jun '26 is ₹ -0.06 crore as compare to the Mar '26 ebitda of ₹ -0.12 crore. This represent the decline of -50% The ebitda of Starsource Multitrade Ltd for the Jun '26 is ₹ 0.02 crore as compare to the Mar '26 ebitda of ₹ -0.07 crore. This represent the decline of -128% The net profit of Prism Medico & Pharmacy Ltd changed from ₹ -0.09 crore to ₹ -0.06 crore over 9 quarters. This represents a CAGR of -16.49% The net profit of Starsource Multitrade Ltd changed from ₹ 0.25 crore to ₹ 0.02 crore over 9 quarters. This represents a CAGR of -67.45% The Dividend Payout of Prism Medico & Pharmacy Ltd changed from 0 % on March 2021 to 0 % on March 2026 . This represents a CAGR of 0.0% over 6 yearsThe Dividend Payout of Starsource Multitrade Ltd changed from 0 % on March 2021 to 0 % on March 2026 . This represents a CAGR of 0.0% over 6 years .

About Prism Medico & Pharmacy Ltd

Prism Medico and Pharmacy Limited was originally incorporated under the name of Woolite Mercantile Company Limited on 21st February, 1985.
The name of the Company was changed from Woolite Mercantile Company Limited to Prism Medico and Pharmacy Limited dated January 9, 2012.
Initially, the Company was engaged into Wholesale and Retail of straw, fodder and other animal/poultry feed.
It also engaged into investments, share trading, and financial activities. Over the past years, the Company was not able to carry out any major operations, resulting it engaged in trading. During FY 2022-23, the main objects of the Memorandum of Association of the Company were altered so as to manufacture, formulate, process, develop, refine, import, export, wholesale and/or retail trade all kinds of pharmaceuticals, antibiotics, drugs, medicines, biological, neutraceuticals, healthcare, ayurvedic and dietary supplement products, medicinal preparations, vaccines, chemicals, chemical products, dry salters, mineral waters, wines, cordials, liquors, soups, broths and other restoratives or foods and also to deal in medicinal goods.

About Starsource Multitrade Ltd

Starsource Multitrade Limited was initially established on August 17, 1942 under the name 'Chemo Pharma Laboratories Limited'.
Name of the Company is given a change in name with due approval from Registrar of Companies effected on August 12, 2025.
Initially, the Company had been making Pharmaceuticals and also diversified into bulk drugs. However due to increase in competition and flow of new drugs, the Company had to dispose the business and pay all its liabilities and dues.
Presently the Company has its own cash resource, with this the Company is proposing to diversify and to take over Sick Company which has excellent future potential.
The Company is in advance in the negotiation to some other company and soon rehab to acquire business in Power and Chemicals. The existing Main Objects of Clause III (A) be altered by replacing the same with the following new Clause to carry on the business of buying, selling, reselling, importing, exporting, transporting, storing, promoting, marketing or supplying, trading, dealing in any manner whatsoever in all type of goods and commodities on retail as well as on wholesale basis in India or elsewhere during the year 2025.

FAQs for the comparison of Prism Medico & Pharmacy Ltd and Starsource Multitrade Ltd

Which company has a larger market capitalization, Prism Medico & Pharmacy Ltd or Starsource Multitrade Ltd?

Market cap of Prism Medico & Pharmacy Ltd is 42 Cr while Market cap of Starsource Multitrade Ltd is 15 Cr

What are the key factors driving the stock performance of Prism Medico & Pharmacy Ltd and Starsource Multitrade Ltd?

The stock performance of Prism Medico & Pharmacy Ltd and Starsource Multitrade Ltd is primarily driven by its robust global client base, consistent revenue growth, strong operational efficiency, strategic investments in digital transformation, client acquisition, and the overall health of the industry. Both companies' performances are also influenced by macroeconomic conditions, currency fluctuations, and industry-specific trends.

What are the recent stock price for Prism Medico & Pharmacy Ltd and Starsource Multitrade Ltd?

As of October 25, 2026, the Prism Medico & Pharmacy Ltd stock price is INR ₹31.52. On the other hand, Starsource Multitrade Ltd stock price is INR ₹105.66.

How do dividend payouts of Prism Medico & Pharmacy Ltd and Starsource Multitrade Ltd compare?

To compare the dividend payouts of Prism Medico & Pharmacy Ltd and Starsource Multitrade Ltd, examine their dividend payout ratio, which indicates how much the companies pay out relative to their share price and earnings. Moreover, consider the consistency and growth of their dividends to gauge their commitment towards returning value to the respective shareholders.

Disclaimer: This information provided above is for informational purposes only and does not constitute investment advice. We use third-party data and recommend conducting thorough research and consulting a certified financial advisor before making investment decisions. We do not endorse specific stocks. Make decisions based on your own research and professional guidance.